Population
Ventricular myocytes
Design
Preclinical
Authors
Loading...
Requires validation in human models before any clinical consideration; leaves open AP-1/SRF targeting in cardiac hypertrophy.
AP-1 factors mediate the induction of the hypertrophy-associated skeletal alpha-actin gene in ventricular myocytes via serum response factor (SRF), without direct binding.
Paradis et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: